Disomy as the genetic underlying mechanisms of loss of heterozigosity in SDHD-paragangliomas.

CONTEXT Succinate dehydrogenase complex, subunit D (SDHD) mutations cause pheochromocytoma/paraganglioma syndrome. SDHD, located at chromosome 11q23, shows a parent-of-origin effect because the disease is observed almost exclusively when the mutation is transmitted from the father, although some cases of maternal transmission have been reported. Several hypotheses have been proposed for this peculiar inheritance pattern, but the underlying mechanisms have not yet been clearly elucidated. OBJECTIVE The objective of the study was to explain the parent-of-origin effect in a family, mainly affected by paternally transmitted paragangliomas, and with a maternally transmitted renal tumor. PATIENTS Peripheral blood DNA from 15 carriers and 7 tumor DNA samples from SDHD-p.Trp5* carriers were studied. METHODS We conducted mutation genotyping and microsatellite marker analysis in germline and tumor DNA and methylation status analysis in tumor DNA by methylation-specific multiplex ligation-dependent probe amplification. RESULTS Mutation genotyping and microsatellite marker analysis demonstrated loss of heterozygosity of the wild-type allele (maternal) in all studied tumors, except the renal tumor, which lost the mutated allele (maternal), and the prostate tumor, which had no loss of heterozygosity. The methylation-specific multiplex ligation-dependent probe amplification demonstrated that the methylation profile corresponded exclusively to the paternal chromosome without genomic loss, suggesting paternal uniparental disomy as the mechanism underlying the parent-of-origin effect in this SDHD family. CONCLUSIONS The paternal uniparental disomy involves the loss of maternally imprinted cell cycle regulators and the overexpression of paternally imprinted growth activators, leading to tumorigenesis in this syndrome.

[1]  S. Ellard,et al.  Hepatoblastoma in a child with a paternally-inherited ABCC8 mutation and mosaic paternal uniparental disomy 11p causing focal congenital hyperinsulinism. , 2013, European journal of medical genetics.

[2]  K. Nathanson,et al.  Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. , 2012, Cancer genetics.

[3]  E. Tobias,et al.  Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect. , 2011, The Journal of clinical endocrinology and metabolism.

[4]  Fiona Douglas,et al.  Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD , 2010, Human mutation.

[5]  G. Mills,et al.  Uniparental disomy in cancer. , 2009, Trends in molecular medicine.

[6]  J. Biegel,et al.  Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors , 2009, PloS one.

[7]  Y. Arai,et al.  Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities , 2008, Genes, chromosomes & cancer.

[8]  P. Caron,et al.  Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation. , 2008, The Journal of clinical endocrinology and metabolism.

[9]  Brigitte Schlegelberger,et al.  Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome. , 2007, Human molecular genetics.

[10]  V. Gorgoulis,et al.  Downregulation of the KIP family members p27KIP1 and p57KIP2 by SKP2 and the role of methylation in p57KIP2 inactivation in nonsmall cell lung cancer , 2006, International journal of cancer.

[11]  H. Spencer,et al.  A census of mammalian imprinting. , 2005, Trends in genetics : TIG.

[12]  E. Jordanova,et al.  Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families , 2004, Oncogene.

[13]  M. Toyota,et al.  Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors , 2002, Oncogene.

[14]  M. Steenman,et al.  Genetics of Beckwith‐Wiedemann syndrome‐associated tumors: Common genetic pathways , 2000, Genes, chromosomes & cancer.

[15]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[16]  C. Powell,et al.  Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  M. James,et al.  Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. , 1997, American journal of human genetics.

[18]  M. James,et al.  Allelotype of head and neck paragangliomas: Allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL , 1994, Genes, chromosomes & cancer.

[19]  B. Tycko Genomic imprinting: mechanism and role in human pathology. , 1994, The American journal of pathology.